UNSPSC 51172903: Acetic acid/oxyquinoline/ricinoleic acid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GU900. This VA Drug Class (GU900) classifies this compound as belonging to the group GENITO-URINARY AGENTS, OTHER.

UNSPSC 51172903 Acetic acid/oxyquinoline/ricinoleic acid is a Commodity code under which state and local governments procure industrial and pharmaceutical chemicals for water treatment, healthcare, and facility operations. Recent solicitations show actual purchasing focused on specific chemical commodities—sodium bisulfite for municipal water pollution control and generic multi-source pharmaceuticals and over-the-counter products for state and local health facilities—rather than the narrow acid compounds the code name suggests. Issuing bodies span municipal water utilities, state cooperative purchasing alliances (MMCAP), and health system networks. The City of Meriden, Connecticut and the Minnesota Department of Administration represent the issuing-body mix, with the latter aggregating demand across multiple participating states including Oregon.

Recent activity concentrates in Connecticut and Minnesota. The City of Meriden issued an IFB for sodium bisulfite supply (solicitation B027-15, due July 29, 2026) with unit pricing evaluated against General Liability and Auto Liability insurance requirements of $1,000,000 to $2,000,000 and performance/payment bonding. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local government facilities, with evaluation weighted 75 percent on price competitiveness, 10 percent on fixed pricing for contract term, and the remainder on administrative compliance and EDI capability. Awarded vendors must maintain contractual relationships with authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and comply with cGMP and Drug Supply Chain Security Act requirements, with contracts effective July 1, 2026 for two years.